PMID: 25764187Mar 13, 2015Paper

Opportunistic testing for urogenital infection with Chlamydia trachomatis in south-western Switzerland, 2012: a feasibility study

Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
F BallyB Spencer

Abstract

The feasibility of opportunistic screening of urogenital infections with Chlamydia trachomatis was assessed in a cross-sectional study in 2012, in two cantons of south-western Switzerland: Vaud and Valais. Sexually active persons younger than 30 years, not tested for C. trachomatis in the last three months, were invited for free C. trachomatis testing by PCR in urine or self-applied vaginal swabs. Of 2,461 consenting participants, 1,899 (77%) were women and all but six (0.3%) submitted a sample. Forty-seven per cent of female and 25% of male participants were younger than 20 years. Overall, 134 (5.5%) of 2,455 tested participants had a positive result and were followed up. Seven per cent of all candidates for screening were not invited, 10% of invited candidates were not eligible, 15% of the eligible candidates declined participation, 5% of tested participants testing positive were not treated, 29% of those treated were not retested after six months and 9% of those retested were positive for C. trachomatis. Opportunistic C. trachomatis testing proved technically feasible and acceptable, at least if free of charge. Men and peripheral rural regions were more difficult to reach. Efforts to increase testing and decrease dropout at ...Continue Reading

References

May 23, 1996·The New England Journal of Medicine·D ScholesW E Stamm
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L OstergaardF Olesen
Nov 20, 2002·Sexually Transmitted Diseases·W John PagetUNKNOWN Swiss Sentinel Surveillance Network of Gynecologists
Nov 17, 2006·Journal of Medical Microbiology·Katia JatonGilbert Greub
Apr 15, 2008·BMC Infectious Diseases·David BaudGilbert Greub
Jun 5, 2010·The Journal of Infectious Diseases·Byron E BatteigerMichael L Rekart
Sep 6, 2011·Emerging Infectious Diseases·David BaudGilbert Greub
Jan 5, 2012·Sexually Transmitted Infections·Ingrid V F van den BroekChristian J P A Hoebe
Dec 21, 2012·BMC Public Health·Sarah C WoodhallPaula Baraitser
Mar 9, 2013·The Journal of Infectious Diseases·William M GeislerEdward W Hook

❮ Previous
Next ❯

Citations

Mar 31, 2016·Future Microbiology·Gilbert GreubKatia Jaton
Dec 24, 2017·BMC Infectious Diseases·Martine Jacot-GuillarmodRoland Sahli
Dec 19, 2020·International Journal of Environmental Research and Public Health·Melanie HaagIsabelle Arnet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Family Planning and Reproductive Health Care
Edward L Chan
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
L WangY Zhang
Annales de dermatologie et de vénéréologie
J C Cêtre, M Sepetjan
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
G AnestadO Steenfeldt-Foss
© 2021 Meta ULC. All rights reserved